7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli

Blood

Volumn 89, Issue 11, 1997, Pages 4078-4084

  Taylor, F B ^a   Coller, B S ^b   Chang, A C K ^b   Peer, G ^b   Jordan, R ^b   Engellener, W ^b   Esmon, C T ^b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4B; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; HEMOLYSIS; HEMOLYTIC ANEMIA; ISCHEMIA; KIDNEY FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0030941811     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.4078     Document Type: Article

References (29)

1. Taylor FB Jr, Chang AK, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT: C4b-binding protein exacerbates the host response to Escherichia coli. Blood 78:357, 1991
2. Taylor FB Jr, Dahlback B, Chang AC, Lockhart MS, Hatanaka K, Peer G, Esmon CT: The role of free protein C and C4b binding protein in regulating the coagulant response to Escherichia coli. Blood 86:2642, 1995
3. Harker LA, Slichter SJ: Platelet and fibrinogen consumption in man. N Engl J Med 287:999, 1972
4. George JN, Broze GJ: Disorders of hemostasis and thrombosis, in Adamson JA (ed): Current Opinion in Hematology. Philadelphia, PA, Current Science 1:327, 1994
5. Remuzzi G, Rossi EC, Misiani R, Marchesi D, Mecca G, de Gaetano G, Donati MB: Prostacyclin and thrombotic microangiopathy. Semin Thromb Hemost 6:391, 1980
6. Brian MC, Neame PB: Thrombotic thrombocytopenia purpura and the hemolytic uremic syndrome. Semin Thromb Hemost 8:186, 1982
7. Coller BS, Scudder LE, Beer J, Gold HK, Folts JD, Cavagnaro J, Jordan R, Wagner C, Iulliucci J, Knight D, Weisman HF, Berger H: Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents. Ann NY Acad Sci 614:193, 1991
8. Coller BS: From bench to bedside. Blockade of platelet GPIIb/ IIIa receptors as an antithrombotic strategy. Circulation 92:2373, 1995
9. Jordan RE, Wagner CL, Mascelli MA, Treacy G, Nedelman MA, Woody JN, Weisman HF, Coller BS: Preclinical development of c7E3 Fab; A mouse/human chimeric monoclonal antibody fragment that inhibits platelet function by blockade of GPIIb/IIIa receptors with observations on the immunogenicity of c7E3 Fab in humans, in Horton MA (ed): Adhesion Receptors as Therapeutic Targets. Boca Raton, FL, CRC, 1996, p 281
10. Coller BS, Anderson K, Weisman HF: New antiplatelet agents: Platelet GPIIb/IIIa antagonists. Thromb Haemost 74:302, 1995
11. Coller BS: Inhibitors of the platelet glycoprotein IIb/IIIa receptor as conjunctive therapy for coronary artery thrombolysis. Coron Artery Dis 3:1016, 1992
12. Coller BS: A new murine monoclonal antibody reports activities dependent on changes in information and/or microenvironment of platelet glycoprotein IIb/IIIa complexes. J Clin Invest 76:101, 1985
13. 2 fragments of a monoclonal antibody to platelet glycoprotein IIb-IIIa receptor. Blood 66:1456, 1985
14. Hinshaw LB, Bracket DJ, Archer LT, Beller L, Wilson MF: Detection of "hyperdynamic state" of sepsis in the baboon during lethal E. coli infusion. J Trauma 23:361, 1983
15. Coller BS, Peerschke EI, Scudder LE, Sullivan CA: A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombesthemic-like state in normal platelets binds to GPIIb-IIIa. J Clin Invest 72:325, 1983
16. Hougie C: Methods of estimating fibrinogen concentration -Thrombin time test, in Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology. New York, NY, McGraw-Hill, 1983, p 1667
17. Wellcome Research Laboratories: Fibrinogen Degradation Products. Thrombo-Wellcotest (Rapid Latex Kit). Purley, Surrey, UK, Southern Press, 1984
18. Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry JN, Esders TW, Figueras J, Goodhue CT, LaRossa DD, Nelson RW, Rand RN, Wu TW: Multilayer film elements for clinical analysis: Applications to representative chemical determinations. Clin Chem 24:1343, 1978
19. Technical Information In Test Methodologies. Rochester, NY, Eastman Kodak Co, 1985
20. Coller BS, Peerschkle EI, Scudder LE, Sullivan CA: Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 61:99, 1983
21. Walsh PN, Schmaier AH: Platelet-coagulant protein interactions, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, 1994, p 629
22. Reverter JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS: Inhibition of platelet-mediated tisuse factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis." J Clin Invest 98:863, 1996
23. Ammar T, Scudder LE, Coller BS: In vitro effects of the platelet GPIIb/IIIa receptor antogonist c7E3 Fab on the activated clotting time. Circulation 92:2373, 1995
24. Moliterno DJ, Califf RM, Aguirre FV, Anderson K, Sigmon KN, Weisman HF, Topol EJ: Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPCI trail). Evaluation of c7E3 Fab in the Prevention of Ischemic Complications trial. Am J Cardiol 75:559, 1995
25. Taylor FB Jr, Kosanke S, Randolph M, Emerson T, Hinshaw LB, White GL, Chang ACK, Peer GT, Blick K: Retrospective description and experimental reconstitution of three different responses of the baboon to lethal E. coli. Circ Shock 42:92, 1994
26. Taylor FB Jr: Baboon models of three variants of the hemostatic response to inflammatory stimuli, in Brigham K (ed): Endo-toxin and the Lungs. New York, NY, Dekker, 1993 p 171
27. Drake TA, Cheng J, Chang ACK, Taylor FB Jr: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142:1458, 1993
28. Voss BL, DeBault LE, Blick KE, Chang ACK, Steiers DL, Hinshaw LB, Taylor FB: Sequential renal alterations in septic shock in the primate. Circ Shock 33:142, 1991
29. Pisciotta AV, Gothschall JL: Clinical features of tnrombocytopenia purpura. Semin Thromb Hemost 6:330, 1980